SynthesisPloS one2019

Study on Dalfampridine in the treatment of Multiple Sclerosis Mobility Disability: A meta-analysis.

Jianzhen Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.